Request for Covid-19 Impact Assessment of this Report

Pharmaceuticals

Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Growth (Status and Outlook) 2022-2028

  • LP 4929107
  • 114 Pages
  • March 2022
  • Pharmaceuticals
Download Sample    Get Discount   
 
As the global economy mends, the 2021 growth of Transient Receptor Potential Cation Channel Subfamily V Member 1 will have significant change from previous year. According to our (LP Information) latest study, the global Transient Receptor Potential Cation Channel Subfamily V Member 1 market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global Transient Receptor Potential Cation Channel Subfamily V Member 1 market size will reach USD million in 2028, growing at a CAGR of % over the analysis period.

The United States Transient Receptor Potential Cation Channel Subfamily V Member 1 market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Transient Receptor Potential Cation Channel Subfamily V Member 1 market, reaching US$ million by the year 2028. As for the Europe Transient Receptor Potential Cation Channel Subfamily V Member 1 landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.

Global main Transient Receptor Potential Cation Channel Subfamily V Member 1 players cover Amgen Inc, Amorepacific Corp, BCN Peptides SA, and Centrexion Therapeutics Corp, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.

This report presents a comprehensive overview, market shares, and growth opportunities of Transient Receptor Potential Cation Channel Subfamily V Member 1 market by product type, application, key players and key regions and countries.

Segmentation by type: breakdown data from 2017 to 2022 in Section 2.3; and forecast to 2028 in section 10.7.

CMX-020

CA-016

DD-04107

Others

Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 10.8.

Ophthalmology

Immunology

Muscle Spasm

Pruritus

Abdominal Pain

Others

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

Americas

United States

Canada

Mexico

Brazil

APAC

China

Japan

Korea

Southeast Asia

India

Australia

Europe

Germany

France

UK

Italy

Russia

Middle East & Africa

Egypt

South Africa

Israel

Turkey

GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.

Amgen Inc

Amorepacific Corp

BCN Peptides SA

Centrexion Therapeutics Corp

Daewoong Pharmaceutical Co Ltd

DoNatur GmbH

Flex Pharma Inc

Grunenthal GmbH

Kyowa Hakko Kirin Co Ltd

Medifron DBT Co Ltd

Neurim Pharmaceuticals Ltd

Pila Pharma AB

Sylentis SAU

Toray Industries Inc

Vitality Biopharma Inc

1 Scope of the Report

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size 2017-2028

2.1.2 Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size CAGR by Region 2017 VS 2022 VS 2028

2.2 Transient Receptor Potential Cation Channel Subfamily V Member 1 Segment by Type

2.2.1 CMX-020

2.2.2 CA-016

2.2.3 DD-04107

2.2.4 Others

2.3 Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size by Type

2.3.1 Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size CAGR by Type (2017 VS 2022 VS 2028)

2.3.2 Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size Market Share by Type (2017-2022)

2.4 Transient Receptor Potential Cation Channel Subfamily V Member 1 Segment by Application

2.4.1 Ophthalmology

2.4.2 Immunology

2.4.3 Muscle Spasm

2.4.4 Pruritus

2.4.5 Abdominal Pain

2.4.6 Others

2.5 Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size by Application

2.5.1 Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size CAGR by Application (2017 VS 2022 VS 2028)

2.5.2 Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size Market Share by Application (2017-2022)

3 Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size by Player

3.1 Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size Market Share by Players

3.1.1 Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue by Players (2020-2022)

3.1.2 Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue Market Share by Players (2020-2022)

3.2 Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Key Players Head office and Products Offered

3.3 Market Concentration Rate Analysis

3.3.1 Competition Landscape Analysis

3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.4 New Products and Potential Entrants

3.5 Mergers & Acquisitions, Expansion

4 Transient Receptor Potential Cation Channel Subfamily V Member 1 by Regions

4.1 Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size by Regions (2017-2022)

4.2 Americas Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size Growth (2017-2022)

4.3 APAC Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size Growth (2017-2022)

4.4 Europe Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size Growth (2017-2022)

4.5 Middle East & Africa Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size Growth (2017-2022)

5 Americas

5.1 Americas Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size by Country (2017-2022)

5.2 Americas Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size by Type (2017-2022)

5.3 Americas Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size by Application (2017-2022)

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size by Region (2017-2022)

6.2 APAC Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size by Type (2017-2022)

6.3 APAC Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size by Application (2017-2022)

6.4 China

6.5 Japan

6.6 Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

7 Europe

7.1 Europe Transient Receptor Potential Cation Channel Subfamily V Member 1 by Country (2017-2022)

7.2 Europe Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size by Type (2017-2022)

7.3 Europe Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size by Application (2017-2022)

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Transient Receptor Potential Cation Channel Subfamily V Member 1 by Region (2017-2022)

8.2 Middle East & Africa Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size by Type (2017-2022)

8.3 Middle East & Africa Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size by Application (2017-2022)

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Forecast

10.1 Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Forecast by Regions (2023-2028)

10.1.1 Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Forecast by Regions (2023-2028)

10.1.2 Americas Transient Receptor Potential Cation Channel Subfamily V Member 1 Forecast

10.1.3 APAC Transient Receptor Potential Cation Channel Subfamily V Member 1 Forecast

10.1.4 Europe Transient Receptor Potential Cation Channel Subfamily V Member 1 Forecast

10.1.5 Middle East & Africa Transient Receptor Potential Cation Channel Subfamily V Member 1 Forecast

10.2 Americas Transient Receptor Potential Cation Channel Subfamily V Member 1 Forecast by Country (2023-2028)

10.2.1 United States Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Forecast

10.2.2 Canada Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Forecast

10.2.3 Mexico Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Forecast

10.2.4 Brazil Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Forecast

10.3 APAC Transient Receptor Potential Cation Channel Subfamily V Member 1 Forecast by Region (2023-2028)

10.3.1 China Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Forecast

10.3.2 Japan Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Forecast

10.3.3 Korea Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Forecast

10.3.4 Southeast Asia Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Forecast

10.3.5 India Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Forecast

10.3.6 Australia Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Forecast

10.4 Europe Transient Receptor Potential Cation Channel Subfamily V Member 1 Forecast by Country (2023-2028)

10.4.1 Germany Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Forecast

10.4.2 France Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Forecast

10.4.3 UK Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Forecast

10.4.4 Italy Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Forecast

10.4.5 Russia Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Forecast

10.5 Middle East & Africa Transient Receptor Potential Cation Channel Subfamily V Member 1 Forecast by Region (2023-2028)

10.5.1 Egypt Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Forecast

10.5.2 South Africa Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Forecast

10.5.3 Israel Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Forecast

10.5.4 Turkey Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Forecast

10.5.5 GCC Countries Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Forecast

10.6 Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Forecast by Type (2023-2028)

10.7 Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Forecast by Application (2023-2028)

11 Key Players Analysis

11.1 Amgen Inc

11.1.1 Amgen Inc Company Information

11.1.2 Amgen Inc Transient Receptor Potential Cation Channel Subfamily V Member 1 Product Offered

11.1.3 Amgen Inc Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue, Gross Margin and Market Share (2020-2022)

11.1.4 Amgen Inc Main Business Overview

11.1.5 Amgen Inc Latest Developments

11.2 Amorepacific Corp

11.2.1 Amorepacific Corp Company Information

11.2.2 Amorepacific Corp Transient Receptor Potential Cation Channel Subfamily V Member 1 Product Offered

11.2.3 Amorepacific Corp Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue, Gross Margin and Market Share (2020-2022)

11.2.4 Amorepacific Corp Main Business Overview

11.2.5 Amorepacific Corp Latest Developments

11.3 BCN Peptides SA

11.3.1 BCN Peptides SA Company Information

11.3.2 BCN Peptides SA Transient Receptor Potential Cation Channel Subfamily V Member 1 Product Offered

11.3.3 BCN Peptides SA Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue, Gross Margin and Market Share (2020-2022)

11.3.4 BCN Peptides SA Main Business Overview

11.3.5 BCN Peptides SA Latest Developments

11.4 Centrexion Therapeutics Corp

11.4.1 Centrexion Therapeutics Corp Company Information

11.4.2 Centrexion Therapeutics Corp Transient Receptor Potential Cation Channel Subfamily V Member 1 Product Offered

11.4.3 Centrexion Therapeutics Corp Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue, Gross Margin and Market Share (2020-2022)

11.4.4 Centrexion Therapeutics Corp Main Business Overview

11.4.5 Centrexion Therapeutics Corp Latest Developments

11.5 Daewoong Pharmaceutical Co Ltd

11.5.1 Daewoong Pharmaceutical Co Ltd Company Information

11.5.2 Daewoong Pharmaceutical Co Ltd Transient Receptor Potential Cation Channel Subfamily V Member 1 Product Offered

11.5.3 Daewoong Pharmaceutical Co Ltd Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue, Gross Margin and Market Share (2020-2022)

11.5.4 Daewoong Pharmaceutical Co Ltd Main Business Overview

11.5.5 Daewoong Pharmaceutical Co Ltd Latest Developments

11.6 DoNatur GmbH

11.6.1 DoNatur GmbH Company Information

11.6.2 DoNatur GmbH Transient Receptor Potential Cation Channel Subfamily V Member 1 Product Offered

11.6.3 DoNatur GmbH Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue, Gross Margin and Market Share (2020-2022)

11.6.4 DoNatur GmbH Main Business Overview

11.6.5 DoNatur GmbH Latest Developments

11.7 Flex Pharma Inc

11.7.1 Flex Pharma Inc Company Information

11.7.2 Flex Pharma Inc Transient Receptor Potential Cation Channel Subfamily V Member 1 Product Offered

11.7.3 Flex Pharma Inc Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue, Gross Margin and Market Share (2020-2022)

11.7.4 Flex Pharma Inc Main Business Overview

11.7.5 Flex Pharma Inc Latest Developments

11.8 Grunenthal GmbH

11.8.1 Grunenthal GmbH Company Information

11.8.2 Grunenthal GmbH Transient Receptor Potential Cation Channel Subfamily V Member 1 Product Offered

11.8.3 Grunenthal GmbH Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue, Gross Margin and Market Share (2020-2022)

11.8.4 Grunenthal GmbH Main Business Overview

11.8.5 Grunenthal GmbH Latest Developments

11.9 Kyowa Hakko Kirin Co Ltd

11.9.1 Kyowa Hakko Kirin Co Ltd Company Information

11.9.2 Kyowa Hakko Kirin Co Ltd Transient Receptor Potential Cation Channel Subfamily V Member 1 Product Offered

11.9.3 Kyowa Hakko Kirin Co Ltd Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue, Gross Margin and Market Share (2020-2022)

11.9.4 Kyowa Hakko Kirin Co Ltd Main Business Overview

11.9.5 Kyowa Hakko Kirin Co Ltd Latest Developments

11.10 Medifron DBT Co Ltd

11.10.1 Medifron DBT Co Ltd Company Information

11.10.2 Medifron DBT Co Ltd Transient Receptor Potential Cation Channel Subfamily V Member 1 Product Offered

11.10.3 Medifron DBT Co Ltd Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue, Gross Margin and Market Share (2020-2022)

11.10.4 Medifron DBT Co Ltd Main Business Overview

11.10.5 Medifron DBT Co Ltd Latest Developments

11.11 Neurim Pharmaceuticals Ltd

11.11.1 Neurim Pharmaceuticals Ltd Company Information

11.11.2 Neurim Pharmaceuticals Ltd Transient Receptor Potential Cation Channel Subfamily V Member 1 Product Offered

11.11.3 Neurim Pharmaceuticals Ltd Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue, Gross Margin and Market Share (2020-2022)

11.11.4 Neurim Pharmaceuticals Ltd Main Business Overview

11.11.5 Neurim Pharmaceuticals Ltd Latest Developments

11.12 Pila Pharma AB

11.12.1 Pila Pharma AB Company Information

11.12.2 Pila Pharma AB Transient Receptor Potential Cation Channel Subfamily V Member 1 Product Offered

11.12.3 Pila Pharma AB Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue, Gross Margin and Market Share (2020-2022)

11.12.4 Pila Pharma AB Main Business Overview

11.12.5 Pila Pharma AB Latest Developments

11.13 Sylentis SAU

11.13.1 Sylentis SAU Company Information

11.13.2 Sylentis SAU Transient Receptor Potential Cation Channel Subfamily V Member 1 Product Offered

11.13.3 Sylentis SAU Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue, Gross Margin and Market Share (2020-2022)

11.13.4 Sylentis SAU Main Business Overview

11.13.5 Sylentis SAU Latest Developments

11.14 Toray Industries Inc

11.14.1 Toray Industries Inc Company Information

11.14.2 Toray Industries Inc Transient Receptor Potential Cation Channel Subfamily V Member 1 Product Offered

11.14.3 Toray Industries Inc Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue, Gross Margin and Market Share (2020-2022)

11.14.4 Toray Industries Inc Main Business Overview

11.14.5 Toray Industries Inc Latest Developments

11.15 Vitality Biopharma Inc

11.15.1 Vitality Biopharma Inc Company Information

11.15.2 Vitality Biopharma Inc Transient Receptor Potential Cation Channel Subfamily V Member 1 Product Offered

11.15.3 Vitality Biopharma Inc Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue, Gross Margin and Market Share (2020-2022)

11.15.4 Vitality Biopharma Inc Main Business Overview

11.15.5 Vitality Biopharma Inc Latest Developments

12 Research Findings and Conclusion

List of Tables

Table 1. Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)

Table 2. Major Players of CMX-020

Table 3. Major Players of CA-016

Table 4. Major Players of DD-04107

Table 5. Major Players of Others

Table 6. Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)

Table 7. Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size by Type (2017-2022) & ($ Millions)

Table 8. Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size Market Share by Type (2017-2022)

Table 9. Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)

Table 10. Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size by Application (2017-2022) & ($ Millions)

Table 11. Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size Market Share by Application (2017-2022)

Table 12. Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue by Players (2020-2022) & ($ Millions)

Table 13. Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue Market Share by Player (2020-2022)

Table 14. Transient Receptor Potential Cation Channel Subfamily V Member 1 Key Players Head office and Products Offered

Table 15. Transient Receptor Potential Cation Channel Subfamily V Member 1 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 16. New Products and Potential Entrants

Table 17. Mergers & Acquisitions, Expansion

Table 18. Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size by Regions 2017-2022 & ($ Millions)

Table 19. Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size Market Share by Regions (2017-2022)

Table 20. Americas Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size by Country (2017-2022) & ($ Millions)

Table 21. Americas Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size Market Share by Country (2017-2022)

Table 22. Americas Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size by Type (2017-2022) & ($ Millions)

Table 23. Americas Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size Market Share by Type (2017-2022)

Table 24. Americas Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size by Application (2017-2022) & ($ Millions)

Table 25. Americas Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size Market Share by Application (2017-2022)

Table 26. APAC Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size by Region (2017-2022) & ($ Millions)

Table 27. APAC Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size Market Share by Region (2017-2022)

Table 28. APAC Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size by Type (2017-2022) & ($ Millions)

Table 29. APAC Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size Market Share by Type (2017-2022)

Table 30. APAC Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size by Application (2017-2022) & ($ Millions)

Table 31. APAC Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size Market Share by Application (2017-2022)

Table 32. Europe Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size by Country (2017-2022) & ($ Millions)

Table 33. Europe Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size Market Share by Country (2017-2022)

Table 34. Europe Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size by Type (2017-2022) & ($ Millions)

Table 35. Europe Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size Market Share by Type (2017-2022)

Table 36. Europe Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size by Application (2017-2022) & ($ Millions)

Table 37. Europe Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size Market Share by Application (2017-2022)

Table 38. Middle East & Africa Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size by Region (2017-2022) & ($ Millions)

Table 39. Middle East & Africa Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size Market Share by Region (2017-2022)

Table 40. Middle East & Africa Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size by Type (2017-2022) & ($ Millions)

Table 41. Middle East & Africa Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size Market Share by Type (2017-2022)

Table 42. Middle East & Africa Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size by Application (2017-2022) & ($ Millions)

Table 43. Middle East & Africa Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size Market Share by Application (2017-2022)

Table 44. Key Market Drivers & Growth Opportunities of Transient Receptor Potential Cation Channel Subfamily V Member 1

Table 45. Key Market Challenges & Risks of Transient Receptor Potential Cation Channel Subfamily V Member 1

Table 46. Key Industry Trends of Transient Receptor Potential Cation Channel Subfamily V Member 1

Table 47. Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size Forecast by Regions (2023-2028) & ($ Millions)

Table 48. Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size Market Share Forecast by Regions (2023-2028)

Table 49. Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size Forecast by Type (2023-2028) & ($ Millions)

Table 50. Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size Market Share Forecast by Type (2023-2028)

Table 51. Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size Forecast by Application (2023-2028) & ($ Millions)

Table 52. Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size Market Share Forecast by Application (2023-2028)

Table 53. Amgen Inc Details, Company Type, Transient Receptor Potential Cation Channel Subfamily V Member 1 Area Served and Its Competitors

Table 54. Amgen Inc Transient Receptor Potential Cation Channel Subfamily V Member 1 Product Offered

Table 55. Amgen Inc Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 56. Amgen Inc Main Business

Table 57. Amgen Inc Latest Developments

Table 58. Amorepacific Corp Details, Company Type, Transient Receptor Potential Cation Channel Subfamily V Member 1 Area Served and Its Competitors

Table 59. Amorepacific Corp Transient Receptor Potential Cation Channel Subfamily V Member 1 Product Offered

Table 60. Amorepacific Corp Main Business

Table 61. Amorepacific Corp Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 62. Amorepacific Corp Latest Developments

Table 63. BCN Peptides SA Details, Company Type, Transient Receptor Potential Cation Channel Subfamily V Member 1 Area Served and Its Competitors

Table 64. BCN Peptides SA Transient Receptor Potential Cation Channel Subfamily V Member 1 Product Offered

Table 65. BCN Peptides SA Main Business

Table 66. BCN Peptides SA Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 67. BCN Peptides SA Latest Developments

Table 68. Centrexion Therapeutics Corp Details, Company Type, Transient Receptor Potential Cation Channel Subfamily V Member 1 Area Served and Its Competitors

Table 69. Centrexion Therapeutics Corp Transient Receptor Potential Cation Channel Subfamily V Member 1 Product Offered

Table 70. Centrexion Therapeutics Corp Main Business

Table 71. Centrexion Therapeutics Corp Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 72. Centrexion Therapeutics Corp Latest Developments

Table 73. Daewoong Pharmaceutical Co Ltd Details, Company Type, Transient Receptor Potential Cation Channel Subfamily V Member 1 Area Served and Its Competitors

Table 74. Daewoong Pharmaceutical Co Ltd Transient Receptor Potential Cation Channel Subfamily V Member 1 Product Offered

Table 75. Daewoong Pharmaceutical Co Ltd Main Business

Table 76. Daewoong Pharmaceutical Co Ltd Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 77. Daewoong Pharmaceutical Co Ltd Latest Developments

Table 78. DoNatur GmbH Details, Company Type, Transient Receptor Potential Cation Channel Subfamily V Member 1 Area Served and Its Competitors

Table 79. DoNatur GmbH Transient Receptor Potential Cation Channel Subfamily V Member 1 Product Offered

Table 80. DoNatur GmbH Main Business

Table 81. DoNatur GmbH Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 82. DoNatur GmbH Latest Developments

Table 83. Flex Pharma Inc Details, Company Type, Transient Receptor Potential Cation Channel Subfamily V Member 1 Area Served and Its Competitors

Table 84. Flex Pharma Inc Transient Receptor Potential Cation Channel Subfamily V Member 1 Product Offered

Table 85. Flex Pharma Inc Main Business

Table 86. Flex Pharma Inc Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 87. Flex Pharma Inc Latest Developments

Table 88. Grunenthal GmbH Details, Company Type, Transient Receptor Potential Cation Channel Subfamily V Member 1 Area Served and Its Competitors

Table 89. Grunenthal GmbH Transient Receptor Potential Cation Channel Subfamily V Member 1 Product Offered

Table 90. Grunenthal GmbH Main Business

Table 91. Grunenthal GmbH Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 92. Grunenthal GmbH Latest Developments

Table 93. Kyowa Hakko Kirin Co Ltd Details, Company Type, Transient Receptor Potential Cation Channel Subfamily V Member 1 Area Served and Its Competitors

Table 94. Kyowa Hakko Kirin Co Ltd Transient Receptor Potential Cation Channel Subfamily V Member 1 Product Offered

Table 95. Kyowa Hakko Kirin Co Ltd Main Business

Table 96. Kyowa Hakko Kirin Co Ltd Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 97. Kyowa Hakko Kirin Co Ltd Latest Developments

Table 98. Medifron DBT Co Ltd Details, Company Type, Transient Receptor Potential Cation Channel Subfamily V Member 1 Area Served and Its Competitors

Table 99. Medifron DBT Co Ltd Transient Receptor Potential Cation Channel Subfamily V Member 1 Product Offered

Table 100. Medifron DBT Co Ltd Main Business

Table 101. Medifron DBT Co Ltd Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 102. Medifron DBT Co Ltd Latest Developments

Table 103. Neurim Pharmaceuticals Ltd Details, Company Type, Transient Receptor Potential Cation Channel Subfamily V Member 1 Area Served and Its Competitors

Table 104. Neurim Pharmaceuticals Ltd Transient Receptor Potential Cation Channel Subfamily V Member 1 Product Offered

Table 105. Neurim Pharmaceuticals Ltd Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 106. Neurim Pharmaceuticals Ltd Main Business

Table 107. Neurim Pharmaceuticals Ltd Latest Developments

Table 108. Pila Pharma AB Details, Company Type, Transient Receptor Potential Cation Channel Subfamily V Member 1 Area Served and Its Competitors

Table 109. Pila Pharma AB Transient Receptor Potential Cation Channel Subfamily V Member 1 Product Offered

Table 110. Pila Pharma AB Main Business

Table 111. Pila Pharma AB Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 112. Pila Pharma AB Latest Developments

Table 113. Sylentis SAU Details, Company Type, Transient Receptor Potential Cation Channel Subfamily V Member 1 Area Served and Its Competitors

Table 114. Sylentis SAU Transient Receptor Potential Cation Channel Subfamily V Member 1 Product Offered

Table 115. Sylentis SAU Main Business

Table 116. Sylentis SAU Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 117. Sylentis SAU Latest Developments

Table 118. Toray Industries Inc Details, Company Type, Transient Receptor Potential Cation Channel Subfamily V Member 1 Area Served and Its Competitors

Table 119. Toray Industries Inc Transient Receptor Potential Cation Channel Subfamily V Member 1 Product Offered

Table 120. Toray Industries Inc Main Business

Table 121. Toray Industries Inc Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 122. Toray Industries Inc Latest Developments

Table 123. Vitality Biopharma Inc Details, Company Type, Transient Receptor Potential Cation Channel Subfamily V Member 1 Area Served and Its Competitors

Table 124. Vitality Biopharma Inc Transient Receptor Potential Cation Channel Subfamily V Member 1 Product Offered

Table 125. Vitality Biopharma Inc Main Business

Table 126. Vitality Biopharma Inc Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 127. Vitality Biopharma Inc Latest Developments

List of Figures

Figure 1. Transient Receptor Potential Cation Channel Subfamily V Member 1 Report Years Considered

Figure 2. Research Objectives

Figure 3. Research Methodology

Figure 4. Research Process and Data Source

Figure 5. Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size Growth Rate 2017-2028 ($ Millions)

Figure 6. Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size Market Share by Type in 2021

Figure 7. Transient Receptor Potential Cation Channel Subfamily V Member 1 in Ophthalmology

Figure 8. Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Market: Ophthalmology (2017-2022) & ($ Millions)

Figure 9. Transient Receptor Potential Cation Channel Subfamily V Member 1 in Immunology

Figure 10. Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Market: Immunology (2017-2022) & ($ Millions)

Figure 11. Transient Receptor Potential Cation Channel Subfamily V Member 1 in Muscle Spasm

Figure 12. Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Market: Muscle Spasm (2017-2022) & ($ Millions)

Figure 13. Transient Receptor Potential Cation Channel Subfamily V Member 1 in Pruritus

Figure 14. Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Market: Pruritus (2017-2022) & ($ Millions)

Figure 15. Transient Receptor Potential Cation Channel Subfamily V Member 1 in Abdominal Pain

Figure 16. Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Market: Abdominal Pain (2017-2022) & ($ Millions)

Figure 17. Transient Receptor Potential Cation Channel Subfamily V Member 1 in Others

Figure 18. Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Market: Others (2017-2022) & ($ Millions)

Figure 19. Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size Market Share by Application in 2021

Figure 20. Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue Market Share by Player in 2021

Figure 21. Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size Market Share by Regions (2017-2022)

Figure 22. Americas Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size 2017-2022 ($ Millions)

Figure 23. APAC Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size 2017-2022 ($ Millions)

Figure 24. Europe Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size 2017-2022 ($ Millions)

Figure 25. Middle East & Africa Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size 2017-2022 ($ Millions)

Figure 26. Americas Transient Receptor Potential Cation Channel Subfamily V Member 1 Value Market Share by Country in 2021

Figure 27. Americas Transient Receptor Potential Cation Channel Subfamily V Member 1 Consumption Market Share by Type in 2021

Figure 28. Americas Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size Market Share by Application in 2021

Figure 29. United States Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size Growth 2017-2022 ($ Millions)

Figure 30. Canada Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size Growth 2017-2022 ($ Millions)

Figure 31. Mexico Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size Growth 2017-2022 ($ Millions)

Figure 32. Brazil Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size Growth 2017-2022 ($ Millions)

Figure 33. APAC Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size Market Share by Region in 2021

Figure 34. APAC Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size Market Share by Application in 2021

Figure 35. China Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size Growth 2017-2022 ($ Millions)

Figure 36. Japan Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size Growth 2017-2022 ($ Millions)

Figure 37. Korea Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size Growth 2017-2022 ($ Millions)

Figure 38. Southeast Asia Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size Growth 2017-2022 ($ Millions)

Figure 39. India Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size Growth 2017-2022 ($ Millions)

Figure 40. Australia Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size Growth 2017-2022 ($ Millions)

Figure 41. Europe Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size Market Share by Country in 2021

Figure 42. Europe Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size Market Share by Type in 2021

Figure 43. Europe Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size Market Share by Application in 2021

Figure 44. Germany Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size Growth 2017-2022 ($ Millions)

Figure 45. France Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size Growth 2017-2022 ($ Millions)

Figure 46. UK Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size Growth 2017-2022 ($ Millions)

Figure 47. Italy Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size Growth 2017-2022 ($ Millions)

Figure 48. Russia Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size Growth 2017-2022 ($ Millions)

Figure 49. Middle East & Africa Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size Market Share by Region in 2021

Figure 50. Middle East & Africa Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size Market Share by Type in 2021

Figure 51. Middle East & Africa Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size Market Share by Application in 2021

Figure 52. Egypt Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size Growth 2017-2022 ($ Millions)

Figure 53. South Africa Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size Growth 2017-2022 ($ Millions)

Figure 54. Israel Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size Growth 2017-2022 ($ Millions)

Figure 55. Turkey Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size Growth 2017-2022 ($ Millions)

Figure 56. GCC Country Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size Growth 2017-2022 ($ Millions)

Figure 57. Americas Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size 2023-2028 ($ Millions)

Figure 58. APAC Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size 2023-2028 ($ Millions)

Figure 59. Europe Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size 2023-2028 ($ Millions)

Figure 60. Middle East & Africa Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size 2023-2028 ($ Millions)

Figure 61. United States Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size 2023-2028 ($ Millions)

Figure 62. Canada Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size 2023-2028 ($ Millions)

Figure 63. Mexico Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size 2023-2028 ($ Millions)

Figure 64. Brazil Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size 2023-2028 ($ Millions)

Figure 65. China Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size 2023-2028 ($ Millions)

Figure 66. Japan Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size 2023-2028 ($ Millions)

Figure 67. Korea Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size 2023-2028 ($ Millions)

Figure 68. Southeast Asia Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size 2023-2028 ($ Millions)

Figure 69. India Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size 2023-2028 ($ Millions)

Figure 70. Australia Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size 2023-2028 ($ Millions)

Figure 71. Germany Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size 2023-2028 ($ Millions)

Figure 72. France Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size 2023-2028 ($ Millions)

Figure 73. UK Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size 2023-2028 ($ Millions)

Figure 74. Italy Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size 2023-2028 ($ Millions)

Figure 75. Russia Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size 2023-2028 ($ Millions)

Figure 76. Spain Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size 2023-2028 ($ Millions)

Figure 77. Egypt Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size 2023-2028 ($ Millions)

Figure 78. South Africa Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size 2023-2028 ($ Millions)

Figure 79. Israel Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size 2023-2028 ($ Millions)

Figure 80. Turkey Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size 2023-2028 ($ Millions)

Figure 81. GCC Countries Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size 2023-2028 ($ Millions)

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025

The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...

  • Publish Date: June 24, 2019
  • $1050
Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts

The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...

  • Publish Date: February 18, 2019
  • $1290
Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts

The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...

  • Publish Date: December 11, 2018
  • $1390